Literature DB >> 24576483

Irisin: a potentially candidate marker for myocardial infarction.

Tuncay Kuloglu1, Suna Aydin2, Mehmet Nesimi Eren3, Musa Yilmaz4, Ibrahim Sahin5, Mehmet Kalayci4, Emine Sarman1, Nalan Kaya1, Osman Fatih Yilmaz1, Ahmet Turk1, Yalcin Aydin6, Mehmet Hanifi Yalcin7, Nimet Uras8, Ali Gurel9, Selcuk Ilhan10, Evrim Gul11, Suleyman Aydin12.   

Abstract

Myocardial infarction (MI) causes energy depletion through imbalance between coronary blood supply and myocardial demand. Irisin produced by the heart reduces ATP production by increasing heat generation. Energy depletion affects irisin concentration in circulation and cardiac tissues, suggesting an association with MI. We examined: (1) irisin expression immunohistochemically in rat heart, skeletal muscle, kidney and liver in isoproterenol (ISO)-induced MI, and (2) serum irisin concentration by ELISA. Rats were randomly allocated into 6 groups (n=6), (i) control, (ii) ISO (1h), (iii) ISO (2h), (iv) ISO (4h), (v) ISO (6h), and (vi) ISO (24h), 200mg ISO in each case. Rats were decapitated and the blood and tissues collected for irisin analysis. Blood was centrifuged at 1792 g for 5 min. Tissues were washed with saline and fixed in 10% formalin for histology. Serum irisin levels gradually decreased from 1h to 24h in MI rats compared with controls, the minimum being at 2h, increasing again after 6h. Cardiac muscle cells, glomerular, peritubular renal cortical interstitial cells, hepatocytes and liver sinusoidal cells and perimysium, endomysium and nucleoi of skeletal muscle were irisin positive, but its synthesis decreased 1-4h after MI. At all time-points, irisin increased near myocardial connective tissue, with production in skeletal muscle, liver and kidney recovering after 6h, although slower than controls. Unique insight into the pathogenesis of MI is shown, and the gradually decrease of serum irisin might be a diagnostic marker for MI.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart; Irisin; Isoproterenol; Kidneys; Myocardial infarction; Skeletal muscle

Mesh:

Substances:

Year:  2014        PMID: 24576483     DOI: 10.1016/j.peptides.2014.02.008

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  36 in total

1.  Irisin Peptide Protects Brain Against Ischemic Injury Through Reducing Apoptosis and Enhancing BDNF in a Rodent Model of Stroke.

Authors:  Yasin Asadi; Fazel Gorjipour; Sedigheh Behrouzifar; Abedin Vakili
Journal:  Neurochem Res       Date:  2018-06-07       Impact factor: 3.996

2.  Sequestration of fatty acids in triglycerides prevents endoplasmic reticulum stress in an in vitro model of cardiomyocyte lipotoxicity.

Authors:  Madeleen Bosma; Dianne H Dapito; Zoi Drosatos-Tampakaki; Ni Huiping-Son; Li-Shin Huang; Sander Kersten; Konstantinos Drosatos; Ira J Goldberg
Journal:  Biochim Biophys Acta       Date:  2014-12

Review 3.  Irisin in metabolic diseases.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Zoe A Efstathiadou; Polyzois Makras; Nikolaos Perakakis; Jannis Kountouras; Christos S Mantzoros
Journal:  Endocrine       Date:  2017-11-23       Impact factor: 3.633

Review 4.  The role of Irisin in multiorgan protection.

Authors:  Jun Ma; Ken Chen
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

5.  Irisin promotes cardiac progenitor cell-induced myocardial repair and functional improvement in infarcted heart.

Authors:  Yu Tina Zhao; Jianguo Wang; Naohiro Yano; Ling X Zhang; Hao Wang; Shouyan Zhang; Gangjian Qin; Patrycja M Dubielecka; Shougang Zhuang; Paul Y Liu; Y Eugene Chin; Ting C Zhao
Journal:  J Cell Physiol       Date:  2018-09-01       Impact factor: 6.384

Review 6.  Does iris(in) bring bad news or good news?

Authors:  Silvio Buscemi; Davide Corleo; Carola Buscemi; Carla Giordano
Journal:  Eat Weight Disord       Date:  2017-09-20       Impact factor: 4.652

7.  Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke.

Authors:  Wen-Jun Tu; Han-Cheng Qiu; Jian-Lei Cao; Qiang Liu; Xian-Wei Zeng; Ji-Zong Zhao
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 8.  Irisin: linking metabolism with heart failure.

Authors:  Jiamin Li; Susu Xie; Lei Guo; Jun Jiang; Han Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

9.  The Changes of Brain Edema and Neurological Outcome, and the Probable Mechanisms in Diffuse Traumatic Brain Injury Induced in Rats with the History of Exercise.

Authors:  Nasrin Soltani; Zahra Soltani; Mohammad Khaksari; Ghasem Ebrahimi; Mojdeh Hajmohammmadi; Maryam Iranpour
Journal:  Cell Mol Neurobiol       Date:  2019-12-14       Impact factor: 5.046

10.  Plasma irisin levels are associated with hemodynamic and clinical outcome in idiopathic pulmonary arterial hypertension patients.

Authors:  Na Sun; Yiqiang Chen; Youli Fan; Jiaxue Chang; Xuan Gao; Yingzi Zhao; Hongru Sun; Zhuozhong Wang; Xia Gu; Jinwei Tian; Bingxiang Wu
Journal:  Intern Emerg Med       Date:  2020-08-14       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.